Paper Details
- Home
- Paper Details
Impact of age, sex and cytochrome P450 genotype on quetiapine and N-desalkylquetiapine serum concentrations: A study based on real-world data from 8118 patients.
Author: HøisethGudrun, MoldenEspen, SmithRobert Løvsletten, SolhaugVigdis, TveitoMarit, WaadeRagnhild Birkeland
Original Abstract of the Article :
AIMS: To investigate the effect of aging, sex and cytochrome P450 (CYP) genotypes on the exposure of quetiapine (QUE) and the pharmacologically active metabolite N-desalkylquetiapine (NDQ). METHODS: Patients with serum concentrations of QUE and NDQ were included retrospectively from a therapeutic d...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1111/bcp.15849
データ提供:米国国立医学図書館(NLM)
Quetiapine and N-Desalkylquetiapine Serum Concentrations: Age, Sex, and CYP Genotype
This research delves into the fascinating world of pharmacogenetics, specifically examining how age, sex, and cytochrome P450 (CYP) genotypes affect the levels of quetiapine (QUE) and its active metabolite, N-desalkylquetiapine (NDQ) in the blood. Think of it like this: imagine our body as a vast desert with unique oases representing different CYP enzymes. These oases process medications, like QUE, in distinct ways. This study used a real-world dataset of 8118 patients to map out how these factors impact drug metabolism in this metaphorical desert.
Age, Sex, and CYP2D6 Genotype Influence Drug Exposure
The study revealed a gradual increase in QUE and NDQ levels with advancing age, particularly in individuals over 70 years old. This finding is significant, as it implies that older individuals might require lower doses of QUE to achieve the desired therapeutic effect, reducing the risk of side effects. Interestingly, females had lower QUE levels but higher NDQ levels than males, suggesting a different metabolic journey for QUE in females. These findings are critical for personalized medicine approaches.
Tailoring Treatment to Individual Profiles
The researchers also uncovered a link between variations in the CYP2D6 gene and NDQ levels. Individuals with reduced CYP2D6 activity, like those with a slower oasis in our desert analogy, exhibited higher NDQ levels. This implies that women over 65 with reduced CYP2D6 activity are at a higher risk of experiencing side effects related to NDQ while taking QUE. This highlights the importance of considering individual genetic variations in drug dosage and treatment strategies.
Dr. Camel's Conclusion
This research shines a light on the complex dance between age, sex, and genetic makeup in influencing how our bodies process medications. It emphasizes the importance of personalized medicine, taking into account these factors for optimal treatment outcomes. Think of it as a personalized desert expedition with tailored routes and supplies, ensuring a safe and effective journey through the intricate landscape of drug metabolism.
Date :
- Date Completed 2023-11-27
- Date Revised 2023-11-27
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.